Clinicopathologic Characterization of Prostatic Cancer in Dogs

Clinicopathologic data in dogs with prostate cancer (PCa) may aid in the differentiation between tumor types and subsequent treatment decisions; however, these data are often unreported. Demographic, clinicopathologic, cytologic, histologic and survival data from dogs with primary prostatic adenocar...

Full description

Bibliographic Details
Main Authors: Demitria M. Vasilatis, Paramita M. Ghosh
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Animals
Subjects:
Online Access:https://www.mdpi.com/2076-2615/14/4/588
_version_ 1797299125563162624
author Demitria M. Vasilatis
Paramita M. Ghosh
author_facet Demitria M. Vasilatis
Paramita M. Ghosh
author_sort Demitria M. Vasilatis
collection DOAJ
description Clinicopathologic data in dogs with prostate cancer (PCa) may aid in the differentiation between tumor types and subsequent treatment decisions; however, these data are often unreported. Demographic, clinicopathologic, cytologic, histologic and survival data from dogs with primary prostatic adenocarcinoma (PRAD) (<i>n</i> = 56) and primary prostatic transitional cell carcinoma (P-TCC) (<i>n</i> = 74) were acquired from a tertiary veterinary teaching hospital from 1992 to 2022. Red blood cell distribution width (RDW) to albumin ratio (RAR) was evaluated for diagnostic utility in differentiating between PRAD and P-TCC. Sections from PRAD tumors (<i>n</i> = 50) were stained for androgen receptor (AR) expression, and laboratory data were compared between AR positive (AR+) and AR negative (AR−) groups. RDW was increased in PRAD, while albumin was decreased (<i>p</i> < 0.05). P-TCC was associated with Melamed-Wolinska bodies (MWB) and necrosis on cytology (<i>p</i> < 0.05). RAR had acceptable diagnostic utility in the differentiation of PCa tumors (AUC = 0.7; <i>p</i> < 0.05). Survival rates and metastases were equivocal. AR+ and AR− PRAD tumors did not differ in clinicopathologic data or survival (<i>p</i> > 0.05). In conclusion, hypoalbuminemia was significantly associated with PRAD and decreased survival, while MWB and necrosis were significantly associated with P-TCC on cytology. These clinicopathologic data may help clinicians differentiate between these tumors ante mortem to guide appropriate treatment and intervention.
first_indexed 2024-03-07T22:46:07Z
format Article
id doaj.art-eb23c0c0f3884653aaf6fb95498ce988
institution Directory Open Access Journal
issn 2076-2615
language English
last_indexed 2024-03-07T22:46:07Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Animals
spelling doaj.art-eb23c0c0f3884653aaf6fb95498ce9882024-02-23T15:04:45ZengMDPI AGAnimals2076-26152024-02-0114458810.3390/ani14040588Clinicopathologic Characterization of Prostatic Cancer in DogsDemitria M. Vasilatis0Paramita M. Ghosh1Department of Urologic Surgery, School of Medicine, University of California Davis, Sacramento, CA 95718, USADepartment of Urologic Surgery, School of Medicine, University of California Davis, Sacramento, CA 95718, USAClinicopathologic data in dogs with prostate cancer (PCa) may aid in the differentiation between tumor types and subsequent treatment decisions; however, these data are often unreported. Demographic, clinicopathologic, cytologic, histologic and survival data from dogs with primary prostatic adenocarcinoma (PRAD) (<i>n</i> = 56) and primary prostatic transitional cell carcinoma (P-TCC) (<i>n</i> = 74) were acquired from a tertiary veterinary teaching hospital from 1992 to 2022. Red blood cell distribution width (RDW) to albumin ratio (RAR) was evaluated for diagnostic utility in differentiating between PRAD and P-TCC. Sections from PRAD tumors (<i>n</i> = 50) were stained for androgen receptor (AR) expression, and laboratory data were compared between AR positive (AR+) and AR negative (AR−) groups. RDW was increased in PRAD, while albumin was decreased (<i>p</i> < 0.05). P-TCC was associated with Melamed-Wolinska bodies (MWB) and necrosis on cytology (<i>p</i> < 0.05). RAR had acceptable diagnostic utility in the differentiation of PCa tumors (AUC = 0.7; <i>p</i> < 0.05). Survival rates and metastases were equivocal. AR+ and AR− PRAD tumors did not differ in clinicopathologic data or survival (<i>p</i> > 0.05). In conclusion, hypoalbuminemia was significantly associated with PRAD and decreased survival, while MWB and necrosis were significantly associated with P-TCC on cytology. These clinicopathologic data may help clinicians differentiate between these tumors ante mortem to guide appropriate treatment and intervention.https://www.mdpi.com/2076-2615/14/4/588clinical pathologycytologydogprostatic adenocarcinomared blood cell distribution widthred blood cell distribution width to albumin ratio
spellingShingle Demitria M. Vasilatis
Paramita M. Ghosh
Clinicopathologic Characterization of Prostatic Cancer in Dogs
Animals
clinical pathology
cytology
dog
prostatic adenocarcinoma
red blood cell distribution width
red blood cell distribution width to albumin ratio
title Clinicopathologic Characterization of Prostatic Cancer in Dogs
title_full Clinicopathologic Characterization of Prostatic Cancer in Dogs
title_fullStr Clinicopathologic Characterization of Prostatic Cancer in Dogs
title_full_unstemmed Clinicopathologic Characterization of Prostatic Cancer in Dogs
title_short Clinicopathologic Characterization of Prostatic Cancer in Dogs
title_sort clinicopathologic characterization of prostatic cancer in dogs
topic clinical pathology
cytology
dog
prostatic adenocarcinoma
red blood cell distribution width
red blood cell distribution width to albumin ratio
url https://www.mdpi.com/2076-2615/14/4/588
work_keys_str_mv AT demitriamvasilatis clinicopathologiccharacterizationofprostaticcancerindogs
AT paramitamghosh clinicopathologiccharacterizationofprostaticcancerindogs